Advisory Alpha’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
4,985
+173
+4% +$47.9K 0.03% 206
2026
Q1
$1.42M Buy
4,812
+82
+2% +$24.4K 0.04% 152
2025
Q4
$1.29M Hold
4,730
0.04% 163
2025
Q3
$1.26M Sell
4,730
-604
-11% -$164K 0.04% 149
2025
Q2
$1.47M Buy
5,334
+5
+0.1% +$1.36K 0.05% 129
2025
Q1
$1.41M Buy
5,329
+120
+2% +$29.6K 0.05% 135
2024
Q4
$1.21M Buy
5,209
+306
+6% +$70.4K 0.04% 138
2024
Q3
$1.08M Buy
4,903
+473
+11% +$97.9K 0.04% 145
2024
Q2
$871K Buy
4,430
+430
+11% +$88.8K 0.03% 159
2024
Q1
$861K Hold
4,000
0.04% 170
2023
Q4
$842K Hold
4,000
0.04% 159
2023
Q3
$801K Sell
4,000
-2,000
-33% -$398K 0.04% 158
2023
Q2
$1.11M Hold
6,000
0.06% 145
2023
Q1
$1.15M Hold
6,000
0.07% 109
2022
Q4
$1.01M Hold
6,000
0.07% 103
2022
Q3
$1.06M Hold
6,000
0.08% 97
2022
Q2
$1.23M Sell
6,000
-50
-0.8% -$10.6K 0.09% 80
2022
Q1
$1.44M Hold
6,050
0.09% 90
2021
Q4
$1.38M Hold
6,050
0.08% 104
2021
Q3
$1.17M Hold
6,050
0.08% 103
2021
Q2
$1.29M Hold
6,050
0.11% 85
2021
Q1
$1.24M Buy
6,050
+28
+0.5% +$5.51K 0.12% 75
2020
Q4
$1.1M Buy
6,022
+22
+0.4% +$3.74K 0.22% 33
2020
Q3
$1.02M Sell
6,000
-17
-0.3% -$2.86K 0.22% 34
2020
Q2
$1.02M Sell
6,017
-1,983
-25% -$355K 0.23% 42
2020
Q1
$1.43M Hold
8,000
0.4% 32
2019
Q4
$1.63M Sell
8,000
-15
-0.2% -$3.08K 0.4% 37
2019
Q3
$1.72M Hold
8,015
0.51% 35
2019
Q2
$1.64M Buy
8,015
+7,975
+19,938% +$1.47M 0.55% 33
2019
Q1
$7.2K Buy
+40
New +$7.07K ﹤0.01% 443

Other funds holding CME

Advisory Alpha's CME Position: Q2 2026 in Review

Advisory Alpha increased its CME Group (CME) stake by 3.6% in Q2 2026, buying an estimated $47.9K and bringing the position to 4,985 shares worth $1.1M. The position accounts for 0.03% of the portfolio, ranked #206.

Advisory Alpha first reported a position in CME in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.72M in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Advisory Alpha held 4,985 shares of CME Group worth $1.1M as of Q2 2026.
  • Advisory Alpha bought 173 CME Group shares in Q2 2026, an estimated $47.9K.
  • CME Group made up 0.03% of Advisory Alpha's portfolio in Q2 2026, its #206 holding.
  • Advisory Alpha first reported a position in CME Group in Q1 2019 and has held it in 30 quarters since.
  • Advisory Alpha's CME Group position peaked at $1.72M in Q3 2019.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.